Mold Immune Reactivity IgE: Cladosporium herbarum : 2.4 Penicillium chrysogen : 4.1 Remaining panel: negative IgG: Broad elevation across multiple molds (including Cladosporium, Aspergillus, Setomelanomma, Curvularia ) Clinical Interpretation of Findings Indicated: Strong mold-specific immune sensitization Intermediate Intervention: Immune Modulation and Neuroregulation Oral immunotherapy (1 5 drops over 5 weeks) L-theanine 200 mg three times daily Clinical Response: Substantial reduction in anxiety Improved cognitive clarity Improved emotional stability Escalation of Binding Therapy Cholestyramine introduced Clinical Response (2 months): Resolution of fatigue Resolution of pain Improved GI symptoms Reduced food intolerance Final Intervention: Glutathione IV glutathione titrated from 1000 mg 3000 mg over 6 weeks Clinical Response: Resolution of insomnia Outcome Neuropsychiatric symptoms resolved Systemic symptoms improved Sleep normalized Discussion Objective improvement may precede symptom resolution Early reductions in C4a and TGF-1 suggest physiologic improvement before full clinical recovery
doi: 10.3390/metabo11030139 31 MartinPLYinJJSengVCaseyOCoreyEMorrisseyCet al
These are sophisticated medications
eClinicalMedicine, Volume 69, 102475 Despain D, Hoffman BL
As an AGEs breaker, GLPs are capable of minimizing the buildup of AGEs in the myocardium which obstructing AGEs-RAGE axis, thereby enhancing the solubility of collagen and reducing fibrotic structural damage
In response to the FDAs complete response letter (CRL), announced Friday by Mesoblast, the New Yorkbased biopharma will conduct a targeted, controlled study in the highest-risk adults with the greatest mortality. Mesoblast noted that the adult study is in line with its overall commercial strategy, which involves a progression from pediatric to adult SR-aGVHD indications
